The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ideaya Biosciences Inc shares valued at $3,016,500 were purchased by Jason Throne on Aug 26 ’24. At $40.22 per share, Jason Throne acquired 75,000 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, WHITE MICHAEL ANTHONY sold 28,500 shares, netting a total of over 1,032,884 in proceeds. Following the sale of shares at $36.24 each, the insider now holds 0 shares.
Before that, Hata Yujiro S had sold 83,856 shares from its account. In a trade valued at $3,597,756, the President and CEO traded Ideaya Biosciences Inc shares for $42.90 each. Upon closing the transaction, the insider’s holdings decreased to 83,856 shares, worth approximately $20.33 million.
As published in a research note from Leerink Partners on November 05, 2024, Ideaya Biosciences Inc [IDYA] has been rated down from an Outperform to a Market perform and the price target has been revised to $27. Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in late October. As of October 15, 2024, Cantor Fitzgerald has initiated its “an Overweight” rating for IDYA. Earlier on July 08, 2024, Mizuho initiated its rating. Their recommendation was “an Outperform” for IDYA stock.
Analyzing IDYA Stock Performance
During the last five days, there has been a surge of approximately 6.54%. Over the course of the year, Ideaya Biosciences Inc shares have dropped approximately -15.71%. Shares of the company reached a 52-week high of $47.74 on 02/15/24 and a 52-week low of $27.52 on 11/01/24. A 50-day SMA is recorded $32.38, while a 200-day SMA reached $38.86. Nevertheless, trading volume fell to 0.51 million shares from 1.17 million shares the previous day.
Support And Resistance Levels for Ideaya Biosciences Inc (IDYA)
According to the 24-hour chart, there is a support level at 29.65, which, if violated, would cause prices to drop to 29.31. In the upper region, resistance lies at 30.48. The next price resistance is at 30.96. RSI (Relative Strength Index) is 46.90 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.34, which suggests the price will decrease in the coming days. Percent R is at 41.33%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
